Floatz logo

Eloxatin

Bipolar Affective Disorder

National Institute of Mental Health (NIMH)Phase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Bipolar Affective Disorder cohort.

Asset / SponsorPhaseRating
MELATONIN
Lars Vedel Kessing
Phase 4BBB
Lacosamide
University of Sao Paulo
Phase 3B
FLUOROURACILUM
National Institute of Mental Health (NIMH)
Phase 2CCC
coq10
National Institute of Mental Health (NIMH)
Phase 2CCC
Calcium folinate pentahydrate
National Institute of Mental Health (NIMH)
Phase 2CCC
PANTOPRAZOLE
National Institute of Mental Health (NIMH)
Phase 2CCC
TACROLIMUS
Bayside Health
N/AD
Nrx-101
D

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →